Advent Pharma Ltd. reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported sales was BDT 131.67 million compared to BDT 126.17 million a year ago. Net income was BDT 26.56 million compared to BDT 25.99 million a year ago. Basic earnings per share from continuing operations was BDT 0.29 compared to BDT 0.28 a year ago.
For the six months, sales was BDT 282.98 million compared to BDT 265.51 million a year ago. Net income was BDT 64.28 million compared to BDT 62.43 million a year ago. Basic earnings per share from continuing operations was BDT 0.69 compared to BDT 0.67 a year ago.